Inventor · disambiguated record
Emma Hickman
Also filed as: HICKMAN EMMA
20 granted patents·2 pending applications·91 citations·filing 2008–2022
94Inventor score
Files withARROWHEAD PHARMACEUTICALS INC8NOVARTIS AG7ARROWHEAD RES CORP3VAN HEEKE GINO3DE FOUGEROLLES ANTONIN1
Top patents by PatentIndex Score
22 records- 0196US7718632B2RNAi inhibition of alpha-ENaC expressionNOVARTIS AG·Filed 2008·Granted May 18, 2010·24 cites·27 claims
- 0295US7943592B2RNAi inhibition of alpha-ENaC expressionNOVARTIS AG·Filed 2010·Granted May 17, 2011·18 cites·20 claims
- 0395US7939508B2RNAi inhibition of alpha-ENaC expressionNOVARTIS AG·Filed 2010·Granted May 10, 2011·18 cites·23 claims
- 0493US8168606B2RNAi inhibition of alpha-ENaC expressionVAN HEEKE GINO·Filed 2010·Granted May 1, 2012·15 cites·23 claims
- 0587US9074212B2RNAi inhibition of alpha-ENaC expressionVAN HEEKE GINO·Filed 2010·Granted Jul 7, 2015·6 cites·20 claims
- 0687US8119612B2RNAi inhibition of alpha-ENaC expressionVAN HEEKE GINO·Filed 2010·Granted Feb 21, 2012·6 cites·23 claims
- 0784US9476052B2RNAi inhibition of alpha-ENaC expressionARROWHEAD RES CORP·Filed 2015·Granted Oct 25, 2016·2 cites·20 claims
- 0882US2022235361A1RNAi Inhibition of Alpha-ENaC ExpressionARROWHEAD PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0981US10544418B2RNAi inhibition of alpha-ENaC expressionARROWHEAD PHARMACEUTICALS INC·Filed 2018·Granted Jan 28, 2020·1 cites·13 claims
- 1081US2022112505A1RNAi Inhibition of Alpha-ENaC ExpressionARROWHEAD PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1178US9752152B2Organic compositions to treat beta-ENaC-related diseasesARROWHEAD PHARMACEUTICALS INC·Filed 2016·Granted Sep 5, 2017·1 cites·15 claims
- 1276US11208662B2RNAi inhibition of alpha-ENaC expressionARROWHEAD PHARMACEUTICALS INC·Filed 2020·Granted Dec 28, 2021·0 cites·21 claims
- 1371US10550391B2Organic compositions to treat beta-ENaC-related diseasesARROWHEAD PHARMACEUTICALS INC·Filed 2018·Granted Feb 4, 2020·0 cites·15 claims
- 1468US10081811B2Organic compositions to treat Beta-ENaC-related diseasesARROWHEAD PHARMACEUTICALS INC·Filed 2017·Granted Sep 25, 2018·0 cites·15 claims
- 1567US9914927B2RNAi inhibition of alpha-ENaC expressionARROWHEAD PHARMACEUTICALS INC·Filed 2016·Granted Mar 13, 2018·0 cites·20 claims
- 1666US9080175B2Organic compositions to treat Beta-ENaC-related diseasesARROWHEAD RES CORP·Filed 2013·Granted Jul 14, 2015·0 cites·15 claims
- 1764US8598335B2Organic compositions to treat Beta-ENaC-related diseasesDE FOUGEROLLES ANTONIN·Filed 2012·Granted Dec 3, 2013·0 cites·15 claims
- 1863US8344130B2Organic compositions to treat Beta-ENaC-related diseasesNOVARTIS AG·Filed 2012·Granted Jan 1, 2013·0 cites·21 claims
- 1963US8344131B2Organic compositions to treat beta-ENaC-related diseasesNOVARTIS AG·Filed 2012·Granted Jan 1, 2013·0 cites·21 claims
- 2063US8344129B2Organic compositions to treat Beta-ENaC-related diseasesNOVARTIS AG·Filed 2012·Granted Jan 1, 2013·0 cites·17 claims
- 2161US9376683B2Organic compositions to treat beta-ENaC-related diseasesARROWHEAD RES CORP·Filed 2015·Granted Jun 28, 2016·0 cites·13 claims
- 2261US8344127B2Organic compositions to treat beta-ENaC-related diseasesNOVARTIS AG·Filed 2011·Granted Jan 1, 2013·0 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Emma Hickman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →